insights_auto
Why is SDZNY up 2,96%?
Dive Deeperchevron_right
SDZNY:OTCMKTS
SANDOZ GROUP ADR
USD 90,82
arrow_upward
+2,96%(+2,61) 1D
15 Okt., 15:09:42 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZNY...
Open
USD 89,99
High
USD 91,34
Low
USD 89,95
Mkt. cap
33,03 mjd
Avg. vol.
26,84 k
Volume
23,79 k
52-wk high
USD 94,15
52-wk low
USD 60,40
Shares outstanding
440,00 m
No. of employees
20 k
Open
USD 89,99
High
USD 91,34
Low
USD 89,95
Mkt. cap
33,03 mjd
Avg. vol.
26,84 k
Volume
23,79 k
52-wk high
USD 94,15
52-wk low
USD 60,40
Shares outstanding
440,00 m
No. of employees
20 k
News stories
From web sources and news partners
ad-hoc-news.de
·
10 uur gelede
Barclays keeps CHF 93.00 target for Sandoz stock
ad-hoc-news.de
·
1 dag gelede
Sandoz agrees to end three Crexont suits and Sandoz stock costs EUR 77.51
ad-hoc-news.de
·
2 dae gelede
Sandoz reports on October 27: Sandoz stock trades 1.66 percent higher
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About SANDOZ GROUP ADR
CEORichard Saynor
Employees20 k
Founded1886
Headquarters-
SectorPharmaceutical industry
Websitesandoz.com